Mortality prediction at admission to intensive care: A comparison of microalbuminuria with acute physiology scores after 24 hours

ObjectiveTo compare low level albumin excretion (microalbuminuria), a marker of systemic capillary permeability, with mortality, Acute Physiologic And Chronic Health Evaluation (APACHE II) score, the Simplified Acute Physiologic (SAP II) score, and their derived mortality probabilities in patients admitted to a general intensive care unit. DesignProspective observational study. SettingA 14-bed intensive care unit in a university teaching hospital. PatientsA total of 140 consecutive patients (59 surgical, 48 medical, 22 trauma, and 11 burns). InterventionsUrine collection within 15 mins of intensive care unit admission for assessment of microalbuminuria. Measurements and Main ResultsMicroalbuminuria, expressed as the albumin-creatinine ratio (ACR: normal, <2.3 mg/mmol), was compared with mortality, APACHE II and SAP II scores and their derived mortality probabilities after 24 hrs, intensive care unit stay, and markers of organ function and inflammation. Median (95% confidence interval) ACR at admission for survivors (n = 115) and nonsurvivors (n = 25) were 4.2 (3.6–6.5) and 17.8 (8.0–40.8) mg/mmol, respectively (p = .0002 Mann Whitney). For 92 surgical, trauma, and burn patients, of whom 81 survived, ACR of >5.9 mg/mmol gave a sensitivity for death of 100%, specificity of 59%, positive predictive value of 25%, and negative predictive value of 100%. Mortality probability receiver operator characteristic curve areas for ACR, APACHE II, and SAP II were 0.843 (p < .0001), 0.793 (p = .0004), and 0.770 (p = .0017), respectively. ACR was associated with intensive care unit stay (p = .0021) and highest serum C-reactive protein (p = .0002), serum creatinine (p < .0001), and bilirubin (p = .0009). For 48 medical patients, of whom 34 survived, admission ACRs for survivors and nonsurvivors were 8.3 (5.7–10.8) and 10.7 (4.1–48.2) mg/mmol, respectively (p = .32). SAP II, but not APACHE II, score was significantly higher for nonsurvivors. ConclusionsFor surgical, trauma, and burn patients, but not medical patients, microalbuminuria within 15 mins of intensive care unit admission predicted death as well as APACHE II and SAP II scores calculated after 24 hrs, and it shows promise as a predictor of outcome.

[1]  I. Roine.  Microalbuminuria: an index of severity in childhood meningitis , 1993, The Pediatric infectious disease journal.

[2]  I. Greaves,et al.  Microalbuminuria as predictor of outcome , 1999, BMJ.

[3]  P. Gosling,et al.  Microproteinuria: response to operation , 1988, British medical journal.

[4]  N. MacIntyre,et al.  A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. , 1995, Critical care medicine.

[5]  M. Lamy,et al.  Sepsis and serum cytokine concentrations. , 1997, Critical care medicine.

[6]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[7]  M. Singer,et al.  Prediction of postoperative cardiac surgical morbidity and organ failure within 4 hours of intensive care unit admission using esophageal Doppler ultrasonography. , 1999, Critical care medicine.

[8]  P. Gosling,et al.  Prediction of posttraumatic adult respiratory distress syndrome by albumin excretion rate eight hours after admission. , 1997, The Journal of trauma.

[9]  W. Shoemaker,et al.  Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury , 1994, Critical care medicine.

[10]  P. Suter,et al.  Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. , 1996, Critical care medicine.

[11]  A. Baue.  Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets? , 1997, Archives of surgery.

[12]  J. V. D. van der Meer,et al.  A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome. , 1998, Cytokine.

[13]  L. Lind,et al.  Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease , 1997, Journal of internal medicine.

[14]  E. Faist,et al.  SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS), MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS), MULTIPLE ORGAN FAILURE (MOF): ARE WE WINNING THE BATTLE? , 1998, Shock.

[15]  S. Nasraway,et al.  Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. , 1998, Lancet.

[16]  P. Gosling,et al.  Is low proteinuria an early predictor of severity of acute pancreatitis? , 1989, Journal of clinical pathology.

[17]  B. Zikria,et al.  Systemic inflammatory response syndrome and magic bullets: finding the target and improving the aim. , 1998, Archives of surgery.

[18]  P. Gosling,et al.  Microproteinuria predicts the severity of systemic effects of reperfusion injury following infrarenal aortic aneurysm surgery , 1994, Annals of vascular surgery.

[19]  T. Yamashita,et al.  Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. , 1999, Critical care medicine.

[20]  J. Bland,et al.  Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. , 1996, Critical care medicine.

[21]  T. Reynolds,et al.  Microalbuminuria is an early response following acute myocardial infarction. , 1991, European heart journal.

[22]  K. Werdan,et al.  Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations. , 1996, Critical care medicine.

[23]  P. Gosling.  Microalbuminuria: a marker of systemic disease. , 1995, British journal of hospital medicine.

[24]  K. Borch-Johnsen,et al.  Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. , 1995, Clinical science.

[25]  B. Rowlands,et al.  The use of tonometry to predict mortality in patients undergoing abdominal aortic aneurysm repair. , 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[26]  Z. Molnár,et al.  Use of microalbuminuria as a predictor of outcome in critically ill patients. , 2000, British journal of anaesthesia.

[27]  H Pastides,et al.  A comparison of methods to predict mortality of intensive care unit patients , 1987, Critical care medicine.

[28]  J. Vincent,et al.  Predictive value of microalbuminuria in medical ICU patients: results of a pilot study. , 2001, Chest.

[29]  F. Lewis,et al.  Prediction of outcome in intensive care unit trauma patients: a multicenter study of Acute Physiology and Chronic Health Evaluation (APACHE), Trauma and Injury Severity Score (TRISS), and a 24-hour intensive care unit (ICU) point system. , 1999, The Journal of trauma.

[30]  S. Nasraway,et al.  Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock , 1998, The Lancet.

[31]  E. K. Alpar,et al.  Early post-traumatic acute respiratory distress syndrome and albumin excretion rate: a prospective evaluation of a 'point-of care' predictive test. , 2001, Injury.

[32]  K. Calman,et al.  INCREASED VASCULAR PERMEABILITY: A MAJOR CAUSE OF HYPOALBUMINAEMIA IN DISEASE AND INJURY , 1985, The Lancet.

[33]  M. Quintel,et al.  Comparison of serum phospholipase A2, polymorphonuclear granulocyte elastase, C-reactive protein and serum amyloid A with the APACHE II score in the prognosis of multiple injured patients , 1994, The clinical investigator.